132 related articles for article (PubMed ID: 6692425)
1. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
Umezawa H
Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
[TBL] [Abstract][Full Text] [Related]
2. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
3. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
4. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
5. [The structure and antitumor activity of antitumor antibiotics--recent progress].
Otake N
Gan To Kagaku Ryoho; 1988 Mar; 15(3):369-79. PubMed ID: 3279909
[TBL] [Abstract][Full Text] [Related]
6. The quantitative structure-selectivity relationship of anthracycline antitumor activity and cardiac toxicity.
Fink SI; Leo A; Yamakawa M; Hansch C; Quinn FR
Farmaco Sci; 1980 Dec; 35(12):965-79. PubMed ID: 7202703
[TBL] [Abstract][Full Text] [Related]
7. Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compounds.
Umezawa H
Biomedicine; 1977 Jul; 26(4):236-49. PubMed ID: 72569
[TBL] [Abstract][Full Text] [Related]
8. [New antineoplastic antibiotics, new analogs, modifiers of biological reactions and oncogene inhibitors].
Viadro MM; Navashin SM
Antibiot Khimioter; 1991 Feb; 36(2):44-8. PubMed ID: 1708985
[No Abstract] [Full Text] [Related]
9. Low molecular weight immunomodifiers produced by microorganisms.
Umezawa H; Ishizuka M
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cancer chemotherapy by green tea.
Sadzuka Y; Sugiyama T; Hirota S
Clin Cancer Res; 1998 Jan; 4(1):153-6. PubMed ID: 9516964
[TBL] [Abstract][Full Text] [Related]
11. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
12. [Immunomodulating properties of antitumor antibiotics].
Viadro MM
Antibiot Med Biotekhnol; 1987 Aug; 32(8):611-7. PubMed ID: 3314693
[No Abstract] [Full Text] [Related]
13. [Low-molecular-weight immunocorrectors of natural origin].
Ivanitskaia LP; Oparina ON; Stekhanova TN; Navashin SM
Antibiot Med Biotekhnol; 1985 Feb; 30(2):131-8. PubMed ID: 3890722
[No Abstract] [Full Text] [Related]
14. [Studies on antitumor antibiotic 1588. III. Experimental treatment of animal tumor (author's transl)].
Yang GZ; Xu ZM
Yao Xue Xue Bao; 1981 Nov; 16(11):811-4. PubMed ID: 6177193
[No Abstract] [Full Text] [Related]
15. [The use of induced and spontaneous animal neoplasms in the experimental therapy of tumors].
Anikin IV; Pliss GB; Vlasov NN
Vopr Onkol; 1993; 39(4-6):161-8. PubMed ID: 7975390
[No Abstract] [Full Text] [Related]
16. [Use of preparations of microbial origin for stimulating antitumor resistance].
Zatula DG; Zaval'niuk AK
Eksp Onkol; 1986; 8(6):3-9. PubMed ID: 3542497
[TBL] [Abstract][Full Text] [Related]
17. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
18. Bacillus Calmette-Guérin versus mitomycin C for the treatment of intermediate-risk non-muscle-invasive bladder cancer: the debate continues.
Sylvester RJ
Eur Urol; 2009 Aug; 56(2):266-8; discussion 268-9. PubMed ID: 19427110
[No Abstract] [Full Text] [Related]
19. [A comparative study of BCG and mitomycin C in superficial carcinomas of the bladder].
Iavarone C; Minocchi L; Arecchi S; Nicolucci D; Porcelli C; D'orazi V; Greco L; Stio F; Martino G; Messinetti S
G Chir; 1996 May; 17(5):289-91. PubMed ID: 8755233
[No Abstract] [Full Text] [Related]
20. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
